🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

107 notícias encontradas para "results"
Photoswitch drug shows early signs of restoring light sensitivity in severely damaged reti
Adelaide University researchers have carried out the first in-human trial of a new type of treatment for a leading cause of blindness in working age adults, with promising results.
Experimental vaccine for 'neglected disease' carried by hundreds of millions of people sho
For a vaccine to be effective, it must do two things. First, it must trigger an immune response. Second, the vaccine must train the body to remember the response so it can fight that same disease in the future. Now, new research shows that the only vaccine being tested to prevent
Elucidating a decades-old mystery of blood clotting
Why is it rare for dangerous blood clots to form in our blood? What happens if this safety mechanism fails? An international team of researchers involving the University of Greifswald has taken a major step toward finding the answer to this central medical question. The results w
Improving growth outcomes for children living with dwarfism
New findings from a trial conducted at Children's Hospital Colorado (Children's Colorado) and University of Colorado (CU) Anschutz School of Medicine demonstrate significantly increased growth rates in children with achondroplasia, the most common form of dwarfism. These results
Baby-led weaning: A solid approach to infant nutrition
When it's time to add solid food to a baby's diet, is it best to spoon-feed purees—the conventional approach—or to allow the baby to feed herself soft finger foods? The second path, called baby-led weaning, has exploded in popularity in the past decade, yet many parents and careg
Investigators report promising results from Phase II trial of targeted therapy for rare bi
Results of the ongoing eNRGy trial, a single-arm, multicenter, global Phase II clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically meaningful efficacy—including a near doubling of p
Brain tau spreads differently in early- and late-onset Alzheimer's disease
A new study from Karolinska Institutet has shown that the amount and distribution of the tau protein in the brain differs between early- and late-onset Alzheimer's disease. The results also indicate that blood tests do not always reflect changes in the brain. The research is publ
Menu photos reveal plate color and size may not drive healthier food choices
The appearance of food images on a menu can influence whether we order large or small portions—or potentially choose healthy or more caloric meals. New research from Flinders University indicates that the color and size of a dining plate can have mixed results in regulating meal
Digital diabetes tool shown to improve patient care and cut health care costs
A new study by University of Manchester researchers has linked a digital platform helping people manage type 2 diabetes to better blood sugar control, improved health and potential long-term NHS cost savings. MyWay Diabetes, an NHS-supported online platform and app—which lets use
Brain tumor vaccine links mutation targeting to eight-year survival gains
A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital and numerous partner institutions
Foto: Ahmed ؜ / Pexels
Ultra-processed foods linked to higher levels of 'bad' fatty acids in blood, study suggest
Consumption of ultra-processed food (UPF) results in a distinct metabolic "signature" in the blood, associated with potentially adverse health conditions, suggests a new study by an international team of researchers. The paper, published in Critical Reviews in Food Science and Nu
Radioligand therapy significantly prolongs progression-free survival in metastatic GEP-NET
Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) compared with targeted therapy